1-20 of 21
Authors: Anton Pozniak
Journal Article
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 9, September 2023, Pages 2361–2365, https://doi.org/10.1093/jac/dkad247
Published: 04 August 2023
Journal Article
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 7, July 2022, Pages 1980–1988, https://doi.org/10.1093/jac/dkac117
Published: 13 April 2022
Journal Article
Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 9, September 2021, Pages 2380–2393, https://doi.org/10.1093/jac/dkab158
Published: 13 June 2021
Journal Article
Switching from boosted PIs to dolutegravir in HIV-infected patients with high cardiovascular risk: 48 week effects on subclinical cardiovascular disease
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 11, November 2020, Pages 3334–3343, https://doi.org/10.1093/jac/dkaa292
Published: 31 July 2020
Journal Article
Five-year follow-up of patients enrolled in the NEAT 001/ANRS 143 randomized clinical trial: NEAT 001/ANRS 143 LONG TERM study
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 6, June 2020, Pages 1618–1622, https://doi.org/10.1093/jac/dkaa056
Published: 25 March 2020
Journal Article
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 3, March 2020, Pages 628–639, https://doi.org/10.1093/jac/dkz479
Published: 21 November 2019
Journal Article
Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1670–1678, https://doi.org/10.1093/jac/dkz068
Published: 27 February 2019
Journal Article
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 8, August 2018, Pages 2186–2196, https://doi.org/10.1093/jac/dky179
Published: 08 June 2018
Journal Article
Estimated generic prices for novel treatments for drug-resistant tuberculosis
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 4, April 2017, Pages 1243–1252, https://doi.org/10.1093/jac/dkw522
Published: 10 January 2017
Journal Article
An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 10, October 2016, Pages 2928–2937, https://doi.org/10.1093/jac/dkw217
Published: 20 June 2016
Journal Article
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 4, April 2016, Pages 1056–1062, https://doi.org/10.1093/jac/dkv427
Published: 24 December 2015
Journal Article
An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 4, April 2014, Pages 1104–1110, https://doi.org/10.1093/jac/dkt447
Published: 24 November 2013
Journal Article
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study Get access
Journal of Antimicrobial Chemotherapy, Volume 66, Issue 8, August 2011, Pages 1886–1896, https://doi.org/10.1093/jac/dkr171
Published: 30 May 2011
Journal Article
Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers
Journal of Antimicrobial Chemotherapy, Volume 63, Issue 6, June 2009, Pages 1233–1243, https://doi.org/10.1093/jac/dkp102
Published: 28 March 2009
Journal Article
Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs Get access
Journal of Antimicrobial Chemotherapy, Volume 62, Issue 5, November 2008, Pages 872–878, https://doi.org/10.1093/jac/dkn330
Published: 18 August 2008
Journal Article
Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients Get access
Journal of Antimicrobial Chemotherapy, Volume 58, Issue 5, November 2006, Pages 1009–1016, https://doi.org/10.1093/jac/dkl379
Published: 19 September 2006
Journal Article
Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients Get access
Journal of Antimicrobial Chemotherapy, Volume 56, Issue 5, November 2005, Pages 908–913, https://doi.org/10.1093/jac/dki354
Published: 04 October 2005
Journal Article
Boosted saquinavir hard gel formulation exposure in HIV-infected subjects: ritonavir 100 mg once daily versus twice daily Get access
Journal of Antimicrobial Chemotherapy, Volume 55, Issue 4, April 2005, Pages 542–545, https://doi.org/10.1093/jac/dki043
Published: 01 April 2005
Journal Article
Surveillance of HIV antiretroviral drug resistance in treated individuals in England: 1998–2000 Get access
Journal of Antimicrobial Chemotherapy, Volume 53, Issue 3, March 2004, Pages 469–473, https://doi.org/10.1093/jac/dkh102
Published: 01 March 2004
Journal Article
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART) Get access
Journal of Antimicrobial Chemotherapy, Volume 53, Issue 3, March 2004, Pages 501–505, https://doi.org/10.1093/jac/dkh116
Published: 01 March 2004
